| mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-06 |
| mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
Y-39983 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.002 |
| mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
| mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.003 |
| mRNA |
BMS-754807 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.003 |
| mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
| mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.004 |
| mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |